Citations for
1CDC34, CNTD1
Cyclin N-Terminal Domain-Containing-1 Coordinates Meiotic Crossover Formation with Cell-Cycle Progression in a Cyclin-Independent Manner.
Gray S, Santiago ER, Chappie JS, Cohen PE.
Cell Rep. Jul 7;32(1):107858. doi: 10.1016/j.celrep.2020.107858 2020
2CDC34, KPNA1, RAG1
Karyopherin alpha 1 is a putative substrate of the RAG1 ubiquitin ligase.
Simkus C, Makiya M, Jones JM.
Mol Immunol 46(7):1319-25. Epub 2008 Dec 31. 2009
3CDC34
Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system.
Ryu KS, Choi YS, Ko J, Kim SO, Kim HJ, Cheong HK, Jeon YH, Choi BS, Cheong C.
BMB Rep 41(12):852-7.PMID: 19123975 2008
4CDC34
Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.
Sadowski M, Mawson A, Baker R, Sarcevic B.
Biochem J 405(3):569-81.PMID: 1746177 2007
5CDC34
Proximity-induced activation of human Cdc34 through heterologous dimerization.
Gazdoiu S, Yamoah K, Wu K, Escalante CR, Tappin I, Bermudez V, Aggarwal AK, Hurwitz J, Pan ZQ.
Proc Natl Acad Sci U S A 102(42):15053-8. Epub 2005 Oct 6.PMID: 16210246 2005
6CDC34
The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels.
Butz N, Ruetz S, Natt F, Hall J, Weiler J, Mestan J, Ducarre M, Grossenbacher R, Hauser P, Kempf D, Hofmann F.
Exp Cell Res 303(2):482-93.PMID: 15652359 2005
7CDC34, DAD1
Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.
Tanaka K, Kondoh N, Shuda M, Matsubara O, Imazeki N, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Yamamoto N, Yamamoto M.
Biochim Biophys Acta 1536(1):1-12. 2001
8CDC34
Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast.
Plon SE, et al.
Proc Natl Acad Sci U S A 90 : 10484-10488. 1993